While the effects of ATRA on ovarian cancer proliferation and apoptosis have been previously investigated [27–31], to date no data has been reported on the effects of ATRA on both annexin A2 and S100A10 expression in serous ovarian cancer cells. This evidence concerns the gene ANXA2 and ovarian cancer.